Click a topic below for an index of articles:

 

New-Material

Home

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

      

Outbreak of Hepatitis C Virus Infection in a Hemodialysis Unit: Potential Transmission by the Hemodialysis Machine?

Infection Control and Hospital Epidemiology

Volume 23 (6) * June 2002 * Original Articles (abstract)

OBJECTIVE

To identify the routes of transmission during an outbreak of infection with hepatitis C virus (Hepatitis C Virus) genotype 2a/2c in a hemodialysis unit.

DESIGN

A matched case–control study was conducted to identify risk factors for Hepatitis C Virus seroconversion. Direct observation and staff interviews were conducted to assess infection control practices. Molecular methods were used in a comparison of Hepatitis C Virus infecting isolates from the case-patients and from patients infected with the 2a/2c genotype before admission to the unit.

    

SETTING

A hemodialysis unit treating an average of 90 patients.

PATIENTS

A case-patient was defined as a patient receiving hemodialysis with a seroconversion for Hepatitis C Virus genotype 2a/2c between January 1994 and July 1997 who had received dialysis in the unit during the 3 months before the onset of disease. For each case-patient, 3 control-patients were randomly selected among all susceptible patients treated in the unit during the presumed contamination period of the case-patient.

RESULTS

Hepatitis C Virus seroconversion was associated with the number of hemodialysis sessions undergone on a machine shared with (odds ratio [OR] per additional session, 1.3; 95% confidence interval [CI95], 0.9 to 1.8) or in the same room as (OR per additional session, 1.1; CI95, 1.0 to 1.2) a patient who was anti-Hepatitis C Virus (genotype 2a/2c) positive. We observed several breaches in infection control procedures. Wetting of transducer protectors in the external pressure tubing sets with patient blood reflux was observed, leading to a potential contamination by blood of the pressure-sensing port of the machine, which is not accessible to routine disinfection. The molecular analysis of Hepatitis C Virus infecting isolates identified among the case-patients revealed two groups of identical isolates similar to those of two patients infected before admission to the unit.

CONCLUSIONS

The results suggest patient-to-patient transmission of Hepatitis C Virus by breaches in infection control practices and possible contamination of the machine. No additional cases have occurred since the reinforcement of infection control procedures and the use of a second transducer protector (Infect Control Hosp Epidemiol 2002;23:328-334).

    

AUTHORS

Drs. Delarocque-Astagneau, de Valk, and Desenclos are from the Institut de Veille Sanitaire; Drs. Baffoy and Astagneau are from the Centre inter-régional de Coordination de la Lutte contre les Infections nosocomiales, Institut biomédical des Cordeliers; Dr. Thiers is from the Centre National de Référence pour l’épidémiologie moléculaire des hépatites virales; Dr. Simon is from the Centre de lutte contre les infections nosocomiales de l’Association pour l’Utilisation du Rein Artificiel (AURA); Dr. de Valk is from the European Programme for Intervention Epidemiology Training; and Drs. Laperche and Couroucé are from the Institut National de la Transfusion Sanguine, Paris, France.

Address reprint requests to Elisabeth Delarocque-Astagneau, InVS, 12, rue du Val d’Osne 94415 Saint-Maurice cedex, Paris, France.

The European Programme for Intervention Epidemiology Training is sponsored by the DGV of the European Commission under agreement number SOC 94 201561 05F01 (94CVVF-057-0).